Skip to main content
Aquaculture for all

WellFish Tech draws new backing as customer base grows

Atlantic Salmon Salmonids Startups +4 more
· 2 min read

Aquaculture technology provider WellFish Tech has completed a significantly oversubscribed interim financing round, reflecting investor confidence in its commercial development and technology platform.

A man in a suit infront of a factory.
Erik Tveteraas, group finance director at WellFish Tech

© WellFish Tech

The funding follows a period of accelerating commercial activity, including new agreements with leading aquaculture companies in Norway and Iceland, alongside continued collaborations across North America, South America, the United Kingdom and Ireland.

As the global aquaculture industry faces increasing pressure to improve fish health outcomes and reduce preventable losses, the funding highlights growing commercial demand for predictive monitoring solutions.

“The response from investors reflects what we are hearing from customers,” said Erik Tveteraas, group finance director at WellFish Tech, in a press release. “The ability to see what is coming 28 days out changes the business, and investors understand what that precision is worth commercially. The demand for physiological data in production decision-making is accelerating, aligned with increasing pressure to improve fish health outcomes.”

Tveteraas added that investor interest was driven not only by the company’s mortality prediction model, WellFish Predict, but also by the company's broader product and intellectual property pipeline, which is focused on expanding the application of physiological biomarkers into additional areas of fish health, welfare and quality assessment.

The round included participation from undisclosed investors across Norway, the United Kingdom and the European Union, spanning venture capital, family office and private investment networks. The financing strengthens WellFish Tech's position as it continues its growth trajectory and prepares for a Series A financing process during 2027.

Company Background

WellFish Tech provides fish farmers with a 28-day mortality forecast built from blood biochemistry – detecting early physiological signs of disease and stress weeks before visible symptoms appear, providing predictive capabilities beyond standard environmental or production data. The method is built on the company’s own patents and non-lethal sampling methodology in line with Norwegian Food Safety Authority (Mattilsynet) regulations.